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(CAT) is recommended by the GOLD report as 
a short, simple questionnaire to measure the im‑
pairment of health status in COPD.3 The question‑
naire comprises 8 items relating to cough sever‑
ity, phlegm, chest tightness, breathlessness, ac‑
tivity limitation, confidence, sleep, and energy. 
The total score ranges from 0 to 40, with a score 
of 0 representing no impairment.3 The tool allows 
a comprehensive symptom assessment, and its 
importance is growing according to the current 
GOLD report. Thus, CAT has been widely used 
for assessing and monitoring COPD, and several 
INTRODUCTION Chronic obstructive pulmonary 
disease (COPD) represents a significant cause of 
mortality and morbidity worldwide.1 According 
to the Global Initiative for Chronic Obstructive 
Pulmonary Disease (GOLD) strategy, the diag‑
nosis of COPD is still based on spirometry, but 
symptom assessment is crucial for proper treat‑
ment decisions.2
From a clinician’s perspective, there is a need 
for a reliable and validated assessment tool that 
could improve communication between the phy‑
sician and patient. The COPD Assessment Test 
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ABSTRACT
INTRODUCTION The COPD Assessment Test (CAT) is a standardized patient–completed tool dedicated 
to assessment of symptom severity. While the Polish CAT version has been used for a few years, it has 
not been validated so far.
OBJECTIVES The aim of the study was to validate the Polish ‑language version of the CAT questionnaire 
by assessing its reproducibility and reliability.
PATIENTS AND METHODS Validation of the Polish ‑language version of the CAT questionnaire was 
a substudy of the international multicenter observational cross ‑sectional POPE survey of patients with 
chronic obstructive pulmonary disease (COPD) in Central and Eastern European countries. The study 
was completed in 395 outpatients with stable disease at least 4 weeks before the survey. Validation 
was performed with the use of the Spearman correlation and Cronbach α coefficients, Cohen κ test, and 
the Bland–Altman procedure.
RESULTS The internal consistency assessed by the Cronbach α coefficient was 0.87 for the question‑
naire and 0.84 to 0.86 for its separate items. The repeatability of the questionnaire was good to very 
good (Cohen κ, 0.76–0.85; P <0.01). The Spearman coefficient for the sum of scores of test–retest 
responses was 0.95 (P <0.01). The Bland–Altman analysis revealed very good test–retest and interrater 
reliability, with the mean difference between test I and test II results of –0.556 (95% CI, –0.345 to 0.767).
CONCLUSIONS The Polish version of the CAT questionnaire is a reproducible and reliable instrument for 
evaluation of patients with COPD and should be recommended for use in clinical practice.
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analysis10: 1) the analysis of statistical properties 
of test items (the assessment of internal consis‑
tency) and the relation of items to general test re‑
sult, and 2) test–retest reliability, that is, the com‑
parison of double tests with the same method (the 
estimation of the internal stability of the test).
The Polish version of the CAT questionnaire 
was self ‑completed by a patient during the visit 
in an outpatient pulmonary department. To as‑
sess test–retest reliability, the questionnaire was 
completed twice by each patient with 1 hour be‑
tween each completion. There is no specific limita‑
tion for the period of time required between each 
completion of the questionnaire in the test–retest 
reliability procedure. Symptoms or complaints 
are expected not to change significantly during 
1 hour in the case of a patient with stable COPD. 
The period of time is also long enough to ensure 
that the patient does not to replicate all answers 
chosen during the previous completion.
The language version questionnaire that was 
validated during the study was translated into 
Polish by GOLD Committee affiliates. The trans‑
lation process was based on the standard proce‑
dures of questionnaire translation.10
Internal consistency Testing for homogeneity 
of the measurement is an important procedure 
assessing the reliability of an instrument. Inter‑
nal consistency is defined as the correlations be‑
tween the items in the scale or within each scale 
domain or correlations between the items and 
the total score. Internal consistency is measured 
by applying the Cronbach α coefficient. The calcu‑
lation is based on an average correlation among 
the items and the number of items in the instru‑
ment; thus, the coefficient reaches the values be‑
tween 0 and 1.11,12
External validity To assess external validi‑
ty, the analysis also included an assessment of 
the association between CAT scores and the mod‑
ified Medical Research Council (mMRC) dyspnea 
scale, as well as spirometry parameters: pre‑ and 
postbronchodilator spirometry (postbronchodi‑
lator forced expiratory volume in 1 second [FEV1, 
l and % predicted], postbronchodilator forced vol‑
ume capacity [FVC, l and % predicted], and post‑
bronchodilator ratio of FEV1 to FVC), as well as 
the 6 ‑minute walk test (6MWT).
Test–retest reliability A reliable measure means 
that it is stable or consistent and produces simi‑
lar results when administrated repeatedly, when 
there is no evidence of change. To assess test–re‑
test reliability, the instrument is administered 
to the same population on 2 occasions (stable 
over the interval between assessments) and the 2 
scores are assessed for consistency. The results 
could be influenced by the possibility of practice 
effects, which can artificially inflate the estimate 
of reliability.13,14 The repeatability of the question‑
naire was assessed using the Bland–Altman pro‑
cedure and the Cohen κ statistical test.
language versions have been published and val‑
idated.4-7 The questionnaire is also available in 
a Polish‑language version (see Supplementary 
material), and it has been widely used in clinical 
practice for the past 10 years. However, the tool 
has not been validated in Poland so far. Therefore, 
the aim of the study was to validate the Polish‑
‑language version of the CAT questionnaire by as‑
sessing its reproducibility and reliability, as only 
validated questionnaires should be recommend‑
ed for research and clinical practice.
Validation of the original English version of 
the questionnaire was completed previously, and 
it was found that the tool had good measurement 
properties with excellent internal consistency.3 
The Cronbach α coefficient for the questionnaire 
was very good (α = 0.88; P <0.05). The validation 
process of the original CAT questionnaire includ‑
ed an intraclass correlation as well as sensitivity 
to change.3 The original version was validated for 
specific items; in addition, selected clinical crite‑
ria were incorporated.
PATIENTS AND METHODS Study design The study 
was a substudy of the POPE project (Phenotypes 
of COPD in Central and Eastern Europe), an inter‑
national multicenter observational cross ‑sectional 
survey of COPD patients in Central and Eastern 
European countries. During the study, the valida‑
tion process of the CAT questionnaire was complet‑
ed at different sites representing a range of Polish 
regions participating in the POPE study.7,8 The co‑
ordinating center was the Medical University of 
Silesia in Katowice. The study was performed in 
accordance with the principles of the Declaration 
of Helsinki. The Ethics Committee of the Polish co‑
ordinating center, after reviewing the study proto‑
col, had decided that the ethical approval was not 
needed due to a noninterventional study design.
The methodology of the POPE study was de‑
scribed in detail elsewhere.7 Patients with a clin‑
ically confirmed diagnosis of COPD established 
at least 12 months before the visit were recruit‑
ed to the study. The diagnosis was based on clin‑
ical data and irreversible airway obstruction on 
spirometry. The inclusion criteria were an age 
of 40 to 80 years and a stable course of disease 
for at least 4 weeks prior to the survey. Smoking 
history was not obligatory, and other exposure 
risk factors were also allowed. Comorbid diseas‑
es were allowed, but exacerbation of any medical 
condition was considered an exclusion criterion.
Validation of a newly developed measure re‑
quires a more complex statistical analysis. If 
an original questionnaire is translated into an‑
other language version, the literal or linguistic 
equivalence of both language versions does not 
ensure that they have the same psychometric 
properties. The consistency of a translated ver‑
sion of the questionnaire can be evaluated using 
its internal consistency and test–retest validity.9
The  validation procedure of the  translat‑
ed Polish version of the CAT questionnaire in‑
volved complex methods applied in a reliability 
ORIGINAL ARTICLE Validation of the Polish ‑language version of CAT 607
a potential improvement of the α value after 
a possible removal of subsequent questions from 
the questionnaire.
To assess the external accuracy of the tool, 
the analysis also included an assessment of the as‑
sociation between CAT scores and the mMRC dys‑
pnea scale, 6MWT, and spirometry parameters.
The repeatability of the responses was as‑
sessed using the Bland–Altman procedure as 
well as the Cohen κ statistical test. The statisti‑
cal agreement was determined with the conven‑
tional scale, with the κ values of 0.81 to 1.00 de‑
noting almost perfect agreement; 0.61 to 0.80, 
substantial agreement; 0.41 to 0.60, moderate 
agreement; 0.20 to 0.40, fair agreement; and 
<0.20, slight agreement.15
The  statistical inferences were based on 
the P level of significance of less than 0.05.
RESULTS Characteristics of the study group 
The  study group comprised 395 ambulato‑
ry patients with COPD (258 men and 37 wom‑
en). The mean (SD) age of patients was 67.9 
(9.7) years, with no significant differences be‑
tween sexes (P ≥0.1). Most patients were former 
smokers (73.67%), followed by current smokers 
(20.76%), passive smokers (2.28%), and non‑
smokers (3.29%). The only difference between 
men and women was a smoking history, with 
men representing significantly higher exposure 
measured as pack ‑years (TABLE 1).
Internal consistency reliability The reliability anal‑
ysis based on the baseline completion of the ques‑
tionnaire, showed the Cronbach α raw coefficient 
of 0.87 and the standardized coefficient of 0.86. 
The impact of particular questions on the general 
level of consistency of the test defined by the val‑
ues of α coefficients ranging from 0.84 to 0.86 is 
presented in TABLE 2. The results of partial correla‑
tion analysis showed that all correlations reached 
a value of 0.5 or higher and ranged from 0.5 to 
0.74. TABLE 2 presents the correlation coefficients 
Statistical analysis Statistical analysis was per‑
formed using standard procedures available in 
the Statistica 12.0 software package (StatSoft 
Inc., New York, New York, United States) and 
SAS, version 9.2 (SAS Institute Inc., Gary, North 
Carolina, United States). The normality of distri‑
bution for continuous variables was assessed by 
the Shapiro–Wilk test. Statistical significance of 
differences between continuous variables was an‑
alyzed by the t test, and in the case of nonnormal 
distribution, the Mann–Whitney test and Wil‑
coxon signed ‑rank test for paired variables were 
used. Differences between categorical variables 
were examined by the χ2 test.
A level of internal consistency of the test was 
assessed by analyzing the correlation of answers 
to questions with a total score of the question‑
naire on the basis of the Cronbach statistics. 
The raw and standardized Cronbach α coefficients 
were calculated (value scaling of variables—an‑
swers to questions with the assumption that 
the standard deviation equals 1). A satisfactory 
level of consistency was defined by the standard‑
ized value of α statistics exceeding 0.70. Apart 
from calculating general α statistics, the impact 
of separate questions on the consistency level 
of the questionnaire was defined by analyzing 
TABLE 1 Characteristics of the study group
Parameter Total (n = 395) Men (n = 258) Women (n = 137) P valuea
Age, y 67 (61; 75) 69 (60; 77) 66 (61; 73) 0.1
Disease duration, y 8 (3; 12) 9 (4; 13) 7 (2–12) 0.09
Age at diagnosis, y 59 (52; 67) 60 (52; 67) 59 (53; 65) 0.6
Smoking, pack ‑years 36 (23; 50) 39.50 (25; 54) 30 (20; 44) 0.0004
BMI, kg/m² 27.59 (24; 30.9) 27.57 (24.31; 31.24) 27.59 (23.07; 30.43) 0.2
6MWD, m 400 (327; 460) 400 (330; 460) 399 (322; 450) 0.9
mMRC dyspnea scale 2 (1; 3) 2 (1; 3) 2 (1; 3) 0.9
Postbronchodilator FEV1, % 
predicted
52.40 (39.48; 68.37) 51.56 (38.24; 67.9) 55.09 (44.39; 68.89) 0.07
FEV1/FVC ratio 0.5 (0.38; 0.6) 0.47 (0.38; 0.59) 0.53 (0.40; 0.62) 0.02
Data are presented as median (Q1; Q3).
a Mann–Whitney test
Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; mMRC, modified Medical Research 
Council; 6MWT, 6 ‑minute walk test
TABLE 2 Impact of the responses to particular questions of the Polish ‑language 
version of the CAT questionnaire on questionnaire’s reliability
Question Correlation coefficient Cronbach α coefficient
Raw Standardized
1 0.50 0.86 0.86
2 0.54 0.86 0.86
3 0.52 0.86 0.86
4 0.67 0.84 0.84
5 0.72 0.84 0.84
6 0.74 0.84 0.84
7 0.61 0.85 0.85
8 0.68 0.85 0.85
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The relation between the CAT and other clinical mea-
sures The analysis of external validity of the CAT 
scores showed significant correlations between 
the Polish ‑language version of the CAT total score 
and mMRC dyspnea scale (R = –0.57), 6MWT (R = 
–0.32), and some pulmonary function parame‑
ters such as FEV1 [l] (R = –0.37), FEV1 [% predict‑
ed] (R = –0.38), FVC [l] (R = –0.12), FVC [% pre‑
dicted] (R = –0.31), and the ratio of FEV1 to FVC 
(R = –0.22) (TABLE 5).
The CAT scores were not affected by the age or 
sex of participants, or by their educational level.
DISCUSSION Our study showed that the psycho‑
metric properties of the Polish version of the CAT 
questionnaire are satisfactory. The validation pro‑
cess included the assessment of internal consis‑
tency, the relation of test items with the general 
test result, and test–retest reliability as the esti‑
mation of the internal stability of the test.
The CAT questionnaire has been translated into 
several languages, some of which have been vali‑
dated. Our results are consistent with those pre‑
viously reported in other populations, both from 
Europe16 and outside of Europe.4,17 Our study 
showed the expected reliability for each item, with 
the Cronbach α coefficient from 0.83 to 0.86 for 
individual items. The Cronbach α coefficient for 
the questionnaire was 0.87 (thus, it could be in‑
terpreted as very good) and was similar to that 
for the original version (α = 0.88).3 For compar‑
ison, the Cronbach α coefficient for Hindi was 
0.83,4 and for Korean, 0.85.5
The test–retest reliability of the Polish ver‑
sion was very good, with a Spearman rank coef‑
ficient of 0.95 (P <0.001) and good repeatability 
also for each question. The test–retest reliability 
of the original version of the questionnaire was 
also very good, with an internal consistency cor‑
relation coefficient of 0.8.3
Unlike in our study, the validation of the origi‑
nal version did not include assessment of the rela‑
tion between questionnaire results and other clin‑
ical parameters such as dyspnea scale or spirom‑
etry. The instruments we used in our study were 
the mMRC dyspnea scale, 6MWT, and selected 
spirometry parameters. We observed significant 
correlations between the total score of the Polish‑
‑language CAT questionnaire and mMRC, 6MWT, 
FEV1, FVC, and the ratio of FEV1 to FVC. In our 
between the responses to particular questions 
and a general result of the test and the values of 
the Cronbach α raw and standardized coefficients 
after a possible removal of a given question from 
the questionnaire.
Correlations between answers for individual 
questions were significant (P <0.05) and reached 
the expected values, ranging from 0.30 to 0.74 
(TABLE 3).
Test–retest reliability and interrater reliability To 
assess test–retest reliability, the instrument was 
administered to the same study group again after 
1 hour. There were no differences between the re‑
sults for single questions or for the total scores 
obtained during the 2 measurements. The cor‑
relations between the total scores from test–re‑
test measurements were very good (Spearman 
rank correlation R = 0.95; P <0.001). The Polish‑
‑language CAT questionnaire was characterized 
by a very good repeatability, with the κ coefficient 
ranging from 0.76 to 0.85 (P <0.01). Details are 
presented in TABLE 4.
According to the Wilcoxon signed ‑rank test for 
paired variables, there were no significant differ‑
ences between the results for single questions as 
well as for the total scores obtained during the 2 
measurements. The Bland–Altman analysis also 
revealed very good test–retest reliability and in‑
terrater reliability, with a mean difference be‑
tween the 2 measurements of –0.556 (95% CI, 
–0.345 to 0.767; FIGURE 1).
TABLE 3 Spearman correlation coefficients for the answers to individual CAT questions
Question no. Question 1 Question 2 Question 3 Question 4 Question 5 Question 6 Question 7 Question 8
Question 1 1.00 0.62 0.30 0.31 0.32 0.34 0.33 0.37
Question 2 0.62 1.00 0.36 0.37 0.34 0.40 0.39 0.34
Question 3 0.30 0.36 1.00 0.38 0.37 0.45 0.46 0.33
Question 4 0.31 0.37 0.38 1.00 0.74 0.62 0.44 0.56
Question 5 0.32 0.34 0.37 0.74 1.00 0.70 0.45 0.65
Question 6 0.34 0.40 0.45 0.62 0.70 1.00 0.54 0.65
Question 7 0.33 0.39 0.46 0.44 0.45 0.54 1.00 0.50
Question 8 0.37 0.34 0.33 0.56 0.65 0.65 0.50 1.00
TABLE 4 Kappa coefficient for each question in 2 CAT measurements (n = 322)
Question Measurement 1 
Mean (SD)
Measurement 2 
Mean (SD)
P valuea κ coefficient 
(95% CI)
Question 1 2.34 (1.22) 2.33 (1.69) 0.8 0.84 (0.79–0.88)
Question 2 2.29 (1.37) 2.26 (1.32) 0.7 0.77 (0.72–0.81)
Question 3 1.73 (1.42) 1.79 (1.43) 0.6 0.77 (0.72–0.82)
Question 4 3.57 (1.47) 3.62 (1.43) 0.3 0.85 (0.81–0.88)
Question 5 2.83 (1.60) 2.94 (1.58) 0.6 0.82 (0.78–0.86)
Question 6 2.08 (1.57) 2.16 (1.59) 0.5 0.82 (0.78–0.86)
Question 7 2.01 (1.59) 2.04 (1.59) 0.7 0.81 (0.76–0.85)
Question 8 2.58 (1.49) 2.63 (1.45) 0.7 0.76 (0.71–0.81)
Total 19.44 (8.54) 19.78 (1.02) 0.6 0.81 (0.77–0.85)
a Difference between 2 CAT measurements by the Wilcoxon signed ‑rank test
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In the case of 6MWT and spirometry param‑
eters, we observed weak but significant inverse 
correlations with the CAT score. This shows that 
in our study, airflow limitation and limited phys‑
ical activity were associated with increasing CAT 
scores. A similar negative correlation between 
the 6MWT results and CAT scores was found in 
a Portuguese study.6 The correlations between 
CAT scores and spirometry were analyzed as 
additional observations only in selected lan‑
guage validation studies, but not in the valida‑
tion study of the original version. The correla‑
tion between CAT results and FEV1 and FVC was 
assessed in the validation of the Arabic version 
but was reported as nonsignificant.22 On the oth‑
er hand, validations of Hindi5 and Portuguese 
versions showed significant correlations.6 Thus, 
most of our results were in line with the obser‑
vations from other studies.5,6,17,18
Study limitations  The fact that we did not as‑
sess the sensitivity to change in our study may 
constitute a potential limitation. Sensitivity to 
change is defined by an instrument’s respon‑
siveness to detect the change. It requires corre‑
lating its scores with other measures reflecting 
any anticipated changes. The responsiveness is 
not required if the validation process concerns 
a translated version of the originally validat‑
ed questionnaire. Therefore, the sensitivity to 
change was not assessed in our study or oth‑
er validation studies, but it seems to be cru‑
cial for the assessment of questionnaire util‑
ity. Additionally, the responsiveness was not 
study the total scores of the questionnaire corre‑
lated significantly with the mMRC dyspnea scale. 
A correlation between limitation of physical ac‑
tivity due to dyspnea and CAT results was also re‑
ported in other studies.6,18,19 The correlation anal‑
ysis showed a weak correlation between dyspnea 
and CAT total scores. The relatively low correla‑
tion between CAT scores and mMRC scale sug‑
gests that both tools should be used as comple‑
mentary measures for a more complex clinical as‑
sessment. The CAT questionnaire covers a wider 
spectrum of the patient’s daily functioning, and 
questions relating to dyspnea are only part of 
the assessment. Although CAT and mMRC are 
proposed as equivalent measures for patient clas‑
sification and treatment stratification,2 the corre‑
lation between both measures reported in other 
studies ranges from 0.29 to 0.62.20,21
FIGURE 1 Repeatability 
of the measurement of 
the Polish version of 
the CAT questionnaire: 
the results of the Bland– 
–Altman procedure
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TABLE 5 Spearman rank correlations between Polish ‑language version of the CAT 
questionnaire and modified Medical Research Council dyspnea scale, 6 ‑minute walk 
test, and selected spirometry values
Variable R P value
mMRC 0.57 0.03
6MWT –0.32 <0.001
FEV1, l –0.37 <0.001
FEV1, % predicted –0.38 <0.001
FVC, l –0.12 <0.001
FVC, % predicted –0.31 <0.001
FEV1/FVC –0.22 <0.001
Abbreviations: see TABLE 1
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assessed in the validation study of the original 
CAT questionnaire.
Strengths of the study A considerable strength of 
our study is a relatively large, community ‑based, 
urban –rural population, as the Polish CAT valida‑
tion study was part of the multicenter POPE study. 
Patients represented different ages and education‑
al levels. Moreover, all participants were recruited 
based on real ‑life criteria of the study; thus, data 
could be translated into everyday practice.
In addition to good data quality, several inde‑
pendent statistical methods suitable for test val‑
idation were used and correlations between CAT 
results and clinical data were analyzed.
Significant heterogeneity of COPD patients due 
to differences in clinical presentation, response to 
therapy, as well as concomitant diseases may im‑
pact the patient’s functioning. Our study showed 
that age and concomitant diseases are associated 
with disease severity, which is in line with other 
studies.23,24 Thus, symptom assessment is crucial 
in the context of treatment and should be based 
on simple and reliable methods. Patient ‑related 
outcome measures should correspond to the spe‑
cific clinical situation and provide an opportuni‑
ty to improve the quality of care. The Polish ver‑
sion of the CAT questionnaire meets all necessary 
criteria of a validation process and could be rec‑
ommended for clinical practice. So far, the CAT is 
one of the available tools to establish a threshold 
at which patients become sufficiently symptomat‑
ic to justify regular treatment. However, further 
research is needed to elucidate some remaining 
issues, including the utility of this tool for clini‑
cal assessment. Consistent use of the same vali‑
dated methods for such assessments would allow 
us to create a more patient ‑oriented approach in 
COPD treatment.
Conclusions The  Polish‑language version of 
the CAT questionnaire is a valid, reproducible, 
and reliable instrument for evaluating patients 
with COPD. This version of the questionnaire 
should be recommended for the assessment of 
COPD in clinical practice in Poland.
SUPPLEMENTARY MATERIAL
Supplementary material (Polish ‑language version of the COPD Assessment 
Test) is available at www.mp.pl/paim.
ARTICLE INFORMATION
ACKNOWLEDGMENTS  We would  like  to  thank GlaxoSmithKline  affili‑
ates for kind permission for the validation process. CAT is a trademark of 
the GlaxoSmithKline group. We would also like to thank the Ludwig Boltzman 
Institute for COPD and Respiratory Epidemiology (Vienna, Austria), the spon‑
sor of the POPE study (ClinicalTrials.gov registry identifier: NCT02119494). 
This research institute received an unrestricted grant from Boehringer Ingel‑
heim. Special thanks to Joshua Lawson for review of the manuscript and 
linguistic remarks.
CONTRIBUTION STATEMENT MF contributed to the concept of 
the study, writing of the original draft, data curation, formal analysis, inves‑
tigation, methodology, as well as manuscript review and editing. GB con‑
tributed to data curation, formal analysis, investigation, methodology, writ‑
ing of the original draft, as well as manuscript review and editing. MC ‑M 
contributed to formal analysis and investigation. RK and AK contributed to 
methodology, formal analysis, and investigation. MT ‑S contributed to formal 
analysis, investigation, and manuscript review. BP and MM contributed to 
ORIGINAL ARTICLE Validation of the Polish ‑language version of CAT 611
23 Kalemci S, Akin F, Sahin A, et al. Relationship between hematological 
parameters and severity of chronic obstructive pulmonary disease. Pol Arch 
Intern Med. 2018; 128: 171‑177.
24 Echave ‑Sustaeta J, Casanova LM, Soler ‑Cataluna J, et al. Comorbidi‑
ty in chronic obstructive pulmonary disease. Related to disease severity? Int 
J Chron Obstruct Pulmon Dis. 2014; 9: 1307‑1314. 
